124 related articles for article (PubMed ID: 34795383)
21. Prognostic factors and impact of surgery in patients with metastatic soft tissue sarcoma at diagnosis: A population-based cohort study.
Zhang L; Akiyama T; Fukushima T; Iwata S; Tsuda Y; Takeshita K; Kawai A; Tanaka S; Kobayashi H
Jpn J Clin Oncol; 2021 May; 51(6):918-926. PubMed ID: 33774673
[TBL] [Abstract][Full Text] [Related]
22. Incidence, mortality, and survival trends of soft tissue and bone sarcoma in Switzerland between 1996 and 2015.
Kollár A; Rothermundt C; Klenke F; Bode B; Baumhoer D; Arndt V; Feller A;
Cancer Epidemiol; 2019 Dec; 63():101596. PubMed ID: 31520938
[TBL] [Abstract][Full Text] [Related]
23. Validation of Different Nutritional Assessment Tools in Predicting Prognosis of Patients with Soft Tissue Spindle-Cell Sarcomas.
Sasaki H; Nagano S; Komiya S; Taniguchi N; Setoguchi T
Nutrients; 2018 Jun; 10(6):. PubMed ID: 29899304
[TBL] [Abstract][Full Text] [Related]
24. Changing odds of survival over time among patients undergoing surgical resection of extremity soft tissue sarcoma.
Kim Y; Kim HS; Cho HS; Han I
J Surg Oncol; 2019 Aug; 120(2):193-199. PubMed ID: 31042013
[TBL] [Abstract][Full Text] [Related]
25. Patterns of Care and Survival in Elderly Patients With Locally Advanced Soft Tissue Sarcoma.
Greto D; Saieva C; Loi M; Desideri I; Delli Paoli C; Lo Russo M; Pezzulla D; Teriaca MA; Lucidi S; Visani L; Terziani F; Olmetto E; Becherini C; Bonomo P; Francolini G; Campanacci DA; Scoccianti G; Livi L
Am J Clin Oncol; 2019 Oct; 42(10):749-754. PubMed ID: 31503061
[TBL] [Abstract][Full Text] [Related]
26. Survival of patients with operable breast cancer (Stages I-III) at a Brazilian public hospital--a closer look into cause-specific mortality.
Balabram D; Turra CM; Gobbi H
BMC Cancer; 2013 Sep; 13():434. PubMed ID: 24063763
[TBL] [Abstract][Full Text] [Related]
27. Semi-Quantitative Calculations of Primary Tumor Metabolic Activity Using F-18 FDG PET/CT as a Predictor of Survival in 92 Patients With High-Grade Bone or Soft Tissue Sarcoma.
Andersen KF; Fuglo HM; Rasmussen SH; Petersen MM; Loft A
Medicine (Baltimore); 2015 Jul; 94(28):e1142. PubMed ID: 26181552
[TBL] [Abstract][Full Text] [Related]
28. [Retrospective analysis and prognostic factors of 208 cases of primary soft tissue sarcoma of extremity].
Li Y; Niu XH; Xu HR
Zhonghua Wai Ke Za Zhi; 2011 Nov; 49(11):964-9. PubMed ID: 22333413
[TBL] [Abstract][Full Text] [Related]
29. Association of core needle biopsy tract resection with local recurrence in extremity soft tissue sarcoma.
Siddiqi MA; Kim HS; Jede F; Han I
Skeletal Radiol; 2017 Apr; 46(4):507-512. PubMed ID: 28175961
[TBL] [Abstract][Full Text] [Related]
30. Statistics of soft-tissue sarcoma in Japan: Report from the Bone and Soft Tissue Tumor Registry in Japan.
Ogura K; Higashi T; Kawai A
J Orthop Sci; 2017 Jul; 22(4):755-764. PubMed ID: 28601416
[TBL] [Abstract][Full Text] [Related]
31. A European project on incidence, treatment, and outcome of sarcoma.
Mastrangelo G; Fadda E; Cegolon L; Montesco MC; Ray-Coquard I; Buja A; Fedeli U; Frasson A; Spolaore P; Rossi CR
BMC Public Health; 2010 Apr; 10():188. PubMed ID: 20384990
[TBL] [Abstract][Full Text] [Related]
32. Adjuvant chemotherapy for soft tissue sarcomas: a 10-year mono-institutional experience.
Brunello A; Rizzato MD; Rastrelli M; Roma A; Maruzzo M; Basso U; Fiduccia P; Buzzaccarini MS; Scarzello G; Rossi CR; Zagonel V
J Cancer Res Clin Oncol; 2016 Mar; 142(3):679-85. PubMed ID: 26547435
[TBL] [Abstract][Full Text] [Related]
33. Clinical outcomes of patients 80 years of age and older with soft tissue sarcoma.
Okamoto M; Yoshimura Y; Aoki K; Kito M; Tanaka A; Suzuki S; Takazawa A; Isobe K; Kato H
J Orthop Sci; 2017 Sep; 22(5):951-957. PubMed ID: 28711412
[TBL] [Abstract][Full Text] [Related]
34. Age-related sarcoma patient experience: results from a national survey in England.
Younger E; Husson O; Bennister L; Whelan J; Wilson R; Roast A; Jones RL; van der Graaf WT
BMC Cancer; 2018 Oct; 18(1):991. PubMed ID: 30333006
[TBL] [Abstract][Full Text] [Related]
35. Prognostic factors in soft tissue sarcoma.
Maretty-Nielsen K
Dan Med J; 2014 Nov; 61(11):B4957. PubMed ID: 25370967
[TBL] [Abstract][Full Text] [Related]
36. Clinical outcomes of non-osteogenic, non-Ewing soft-tissue sarcoma of bone--experience of the Toronto Sarcoma Program.
Veitch ZW; Fasih S; Griffin AM; Al-Ezzi EM; Gupta AA; Ferguson PC; Wunder JS; Abdul Razak AR
Cancer Med; 2020 Dec; 9(24):9282-9292. PubMed ID: 33063945
[TBL] [Abstract][Full Text] [Related]
37. [Increasing frequency of soft tissue sarcomas in The Netherlands].
Schuurman B; Meyer S; Cuesta MA; Nauta JJ
Ned Tijdschr Geneeskd; 1992 Aug; 136(32):1556-60. PubMed ID: 1528282
[TBL] [Abstract][Full Text] [Related]
38. Oncological and prognostic analysis of soft tissue sarcoma of the elbow: report using the bone and soft tissue tumor registry in Japan.
Emori M; Iba K; Murahashi Y; Shimizu J; Sonoda T; Wada T; Yamashita T; Kawai A
Jpn J Clin Oncol; 2021 Nov; 51(11):1608-1614. PubMed ID: 34322711
[TBL] [Abstract][Full Text] [Related]
39. A prediction model for treatment decisions in high-grade extremity soft-tissue sarcomas: Personalised sarcoma care (PERSARC).
van Praag VM; Rueten-Budde AJ; Jeys LM; Laitinen MK; Pollock R; Aston W; van der Hage JA; Dijkstra PDS; Ferguson PC; Griffin AM; Willeumier JJ; Wunder JS; van de Sande MAJ; Fiocco M
Eur J Cancer; 2017 Sep; 83():313-323. PubMed ID: 28797949
[TBL] [Abstract][Full Text] [Related]
40. Soft Tissue Sarcomas: A 16-Year Experience of a Tertiary Referral Hospital in North Jordan.
Alorjani MS; Matalka II; Alfaqih MA; Jahmani RA; Alsinglawi BS; Nimri FM; Matalka MI; Amr SS
Medicina (Kaunas); 2022 Jan; 58(2):. PubMed ID: 35208522
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
